These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33259728)

  • 21. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
    Li J; Wang Y; Wang X; Yang Q
    World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Verification of Core Genes in Colorectal Cancer.
    Xu H; Ma Y; Zhang J; Gu J; Jing X; Lu S; Fu S; Huo J
    Biomed Res Int; 2020; 2020():8082697. PubMed ID: 32462020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Key mRNAs and Pathways in Colorectal Cancer.
    Hou X; Hou N; Fu J; He X; Xiong H; Xie W; Jia G; Zuo X; Qin X; Pang M
    Nutr Cancer; 2021; 73(6):1040-1046. PubMed ID: 32586129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of key genes in colorectal cancer using random walk with restart.
    Cui X; Shen K; Xie Z; Liu T; Zhang H
    Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data.
    Manoochehri H; Jalali A; Tanzadehpanah H; Taherkhani A; Saidijam M
    J Gastrointest Cancer; 2022 Sep; 53(3):649-668. PubMed ID: 34432208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study.
    Yong L; YuFeng Z; Guang B
    Int J Surg; 2018 Nov; 59():80-89. PubMed ID: 30296597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of gene expression data identifies key genes and pathways in colorectal cancer.
    Hozhabri H; Lashkari A; Razavi SM; Mohammadian A
    Med Oncol; 2021 Jan; 38(1):7. PubMed ID: 33411100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights regarding novel biomarkers and the pathogenesis of primary colorectal carcinoma based on bioinformatic analysis.
    Wang YR; Meng LB; Su F; Qiu Y; Shi JH; Xu X; Luo QF
    Comput Biol Chem; 2020 Apr; 85():107229. PubMed ID: 32058945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
    Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
    Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W
    DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
    Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
    Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
    Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
    Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
    Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Hub Gene TIMP1 and Relative ceRNAs Regulatory Network in Colorectal Cancer.
    Qin YF; Li GM; Wang G; Kong DJ; Wang HD; Zhao YM; Hao JP; Qin H; Sun DQ; Wang H
    Ther Clin Risk Manag; 2021; 17():889-901. PubMed ID: 34475758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer.
    Misbah M; Kumar M; Lee KH; Shen SC
    Biomed Res Int; 2022; 2022():3825760. PubMed ID: 36193307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
    Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing.
    Wang S; Zhang C; Zhang Z; Qian W; Sun Y; Ji B; Zhang Y; Zhu C; Ji D; Wang Q; Sun Y
    Cancer Med; 2017 Aug; 6(8):1976-1987. PubMed ID: 28745433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.